Generic Name and Formulations:
Lodoxamide tromethamine 0.1%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for ALOMIDE:
Vernal conjunctivitis, keratoconjunctivitis, or keratitis.
Adults and Children:
<2yrs: not recommended. ≥2yrs: 1–2 drops 4 times daily for up to 3 months.
Do not wear soft contact lenses during treatment.
Pregnancy (Cat.B). Nursing mothers.
Mast cell stabilizer.
Transient burning, stinging or discomfort, pruritus, blurred vision, dry eye, discharge, hyperemia, crystalline deposits, foreign body sensation, headache.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Cycle Patterns Associated With Treatment Response in Bipolar Disorders
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder